NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2025)
NovaBridge Biosciences (NBP) reported Cash from Investing Activities of $105.0 million for Q4 2025, up 1176.84% on a QoQ basis from $8.2 million in Q4 2020.
NovaBridge Biosciences (NBP) has 3 years of Cash from Investing Activities data on file, last reported at $105.0 million in Q4 2025.
- Quarterly Cash from Investing Activities changed N/A year-over-year to $105.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $105.0 million (up 416.1% YoY) and the FY2025 annual result came in at $105.0 million, up 570.93% from the prior year.
- Cash from Investing Activities rose to $105.0 million in Q4 2025 per NBP's latest filing, from $8.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $105.0 million in Q4 2025 and bottomed at $105.0 million in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 104.97 Mn |
| Dec 31, 2025 | 104.97 Mn |
| Dec 31, 2020 | 8.22 Mn |
| Dec 31, 2020 | 8.22 Mn |
| Sep 30, 2020 | -41.43 Mn |
| Sep 30, 2020 | -41.43 Mn |
| Dec 31, 2019 | 10.97 Mn |
| Dec 31, 2019 | 10.97 Mn |